Health and population

Health and population dynamics are intertwined, embodying an intricate relationship with significant implications on the Sustainable Development Goals (SDGs). Health is fundamentally at the center of these 17 global goals, aimed to transform the world by 2030. Specifically, Goal 3 endeavors to "Ensure healthy lives and promote well-being for all at all ages." It acknowledges that health is pivotal to human life quality, social cohesion, and sustainable development. Inextricably linked to this are the complexities of population dynamics, including growth rates, age structure, fertility and mortality rates, and migration patterns.

With the world's population projected to exceed 9.7 billion by 2050, the pressure on health systems will undoubtedly escalate. The demographic transition, with an aging population and an increasing prevalence of non-communicable diseases, poses new challenges for health systems globally. Additionally, areas with high fertility rates often overlap with extreme poverty, resulting in heightened health risks, including higher maternal and child mortality rates, malnutrition, and infectious diseases.

Moreover, rapid urbanization and migration present both opportunities and threats to health. While urban areas may provide better access to healthcare, they also harbor risks of disease transmission, air and water pollution, and social determinants of health like inadequate housing and social inequality. Simultaneously, migrants often face disproportionate health risks due to unstable living conditions, exploitation, and limited access to healthcare services.

Achieving the SDGs will necessitate comprehensive approaches that consider the intricate interplay of health and population dynamics. It means strengthening health systems, promoting universal health coverage, and addressing social determinants of health. It also implies crafting policies that recognize demographic realities and foster an environment conducive to sustainable development. Only by understanding and harnessing these dynamics can the world meaningfully progress towards realizing the SDGs, ensuring healthy lives and well-being for all.

Rare Disease Day is the globally-coordinated movement working towards equity in social opportunity, healthcare and access to diagnosis and therapies for those living with a rare disease.
This Health Policy paper supports SDG 3 and 10 by discussing the situation of Indigenous peoples of Canada in the context of "opt out" organ donation in Novia Scotia, the first area in North America to pass such legislation. The paper explores the potential impacts and issues of such legislation on Indigenous peoples, and makes a series of recommendations which would help to respect the rights and interests of these communities.
This Personal View supports SDG 3 and 10 by discussing the ethical issues surrounding the use of psychedelic pharmacotherapies in Western medicine; as some of these agents are used in traditional medicines by Indigenous people. The authors make a series of recommendations on how these issues can be addressed.
This Article supports SDG 3 by assessing whether access to free health prenatal health care affects adverse outcomes in newborns in Switzerland. The findings suggest that the health-care policy impacted some, but not all, outcomes.
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by introducing the AI transformation of public health (PubHealth) uniting healthcare systems with the central terms, concepts, and history of PubHealth from ancient quarantines to modern vaccines including milestone developments as successful responses to chronic and infectious diseases, sanitation, workplace safety, poverty, and wars.
For Rare Disease Day 2023, RELX's Global Head of Corporate Responsibility, Márcia Balisciano, speaks to Shiv Gaglani, CEO & Co-Founder of Osmosis.
This content supports the SDG Goal 3: Good health and well-being by providing the current knowledge regarding standard therapy and suggestions based on the literature for AIH patients being nonresponders to standard therapy and difficult-to-manage AIH patients to standard therapy.
Elsevier,

Clinical Decision Support and Beyond (Third Edition): Progress and Opportunities in Knowledge-Enhanced Health and Healthcare, 2023, Pages 715-725

This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by discussing the components of a technical infrastructure to support PHM, including data sources (registries, electronic health records), data analytics tools, patient outreach and engagement tools, and patient tracking dashboards along with real-world examples of PHM programs focused on chronic disease management, genetic testing for hereditary cancers, colorectal cancer screening, COVID-19 testing and vaccination, and tobacco cessation.
This content supports the SDG Goal 3: Good health and well-being by presenting the antiviral strategies available to treat viral infections, those used to treat chronic viral hepatitis, and the mechanisms of action of drugs approved or at the developmental stage.
Evaluating the bias and fairness of ML models has drawn much attention in the machine learning and statistics community. Researchers have proposed methods to assess and mitigate the bias for various applications that could adversely affect underrepresented groups, like recidivism prediction, credit risk prediction, and income prediction.

Pages